UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 28, 2022

Accession Number:	0001193125-22-063655
Submission Type:	POS AM
CIK: 0001680581 Company Name: Fulcrum Therapeutics, Inc. File Number: 333-260754